Two further studies indicate that CCNE2 is expressed at significant levels in recurrent disease, including therapy-related myeloid leukemia [120] and recurrent non small cell lung carcinoma [121]. This evidence concerns the gene CCNE2 and non-small cell lung carcinoma.